OTCMKTS:INNV InnovAge - INNV Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. $6.27 +0.31 (+5.20%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$5.80▼$6.3050-Day Range$5.77▼$7.7252-Week Range$3.39▼$8.03Volume34,702 shsAverage Volume27,866 shsMarket Capitalization$850.21 millionP/E RatioN/ADividend YieldN/APrice Target$6.48 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest InnovAge MarketRank™ ForecastAnalyst RatingHold1.80 Rating ScoreUpside/Downside3.4% Upside$6.48 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.25) to ($0.08) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.64 out of 5 stars 0.9 Analyst's Opinion Consensus RatingInnovAge has received a consensus rating of Hold. The company's average rating score is 1.80, and is based on no buy ratings, 4 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.48, InnovAge has a forecasted upside of 3.4% from its current price of $6.27.Amount of Analyst CoverageInnovAge has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for INNV. Previous Next 0.0 Dividend Strength Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INNV. Previous Next 1.2 News and Social Media Coverage News SentimentInnovAge has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.25% of the stock of InnovAge is held by insiders.Percentage Held by InstitutionsOnly 12.44% of the stock of InnovAge is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for InnovAge are expected to grow in the coming year, from ($0.25) to ($0.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -22.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -22.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 2.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About InnovAge (OTCMKTS:INNV) StockInnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. As of June 30, 2022, it served approximately 6,650 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address INNV Stock News HeadlinesMarch 9, 2023 | finance.yahoo.comInnovAge Holding Corp. (INNV) Loses -7.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerMarch 1, 2023 | finance.yahoo.comInnovAge Names Christine Bent as Chief Operations OfficerMarch 21, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. February 10, 2023 | finance.yahoo.comInnovAge Holding Corp. (NASDAQ:INNV) Q2 2023 Earnings Call TranscriptJanuary 24, 2023 | finance.yahoo.comInnovAge to Announce Fiscal Second Quarter 2023 Financial Results and Host Conference Call Tuesday, February 7, 2023January 24, 2023 | finance.yahoo.comInnovAge released from sanctions, can enroll Colorado patients once moreJanuary 23, 2023 | finance.yahoo.comState and Federal Regulators Lift Sanctions at InnovAge’s Colorado PACE CentersJanuary 5, 2023 | finance.yahoo.comInnovAge Announces Participation at the 41st Annual J.P. Morgan Healthcare ConferenceMarch 21, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. December 14, 2022 | finance.yahoo.comShareholders in InnovAge Holding (NASDAQ:INNV) have lost 14%, as stock drops 5.6% this past weekNovember 22, 2022 | finance.yahoo.comInnovAge Announces Release of CMS Sanction in Sacramento CenterNovember 8, 2022 | finance.yahoo.comInnovAge Holding Corp. (INNV) Reports Q1 Loss, Lags Revenue EstimatesNovember 8, 2022 | finance.yahoo.comInnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2022November 1, 2022 | finance.yahoo.comEarnings Preview: InnovAge Holding Corp. (INNV) Q1 Earnings Expected to DeclineOctober 25, 2022 | finance.yahoo.comInnovAge to Announce Fiscal First Quarter 2023 Financial Results and Host Conference Call Tuesday, November 8, 2022October 10, 2022 | bizjournals.comInitiating recovery modeOctober 6, 2022 | uk.investing.comSotera Health, SMART Global And Other Big Losers From Wednesday By Benzinga - Investing.com UKSeptember 24, 2022 | nasdaq.com4 Toxic Stocks That May Risk Your Peace and Prosperity - NasdaqSeptember 23, 2022 | nasdaq.comZacks.com featured highlights InnovAge Holding, Spirit AeroSystems Holdings, Tandem Diabetes Care and HCI Group - NasdaqSeptember 21, 2022 | nasdaq.comTuesday 9/20 Insider Buying Report: SPOK, INNVSeptember 18, 2022 | msn.comInnovAge Holding Earnings Perspective: Return On Capital EmployedSeptember 16, 2022 | benzinga.comInnovAge Holding Earnings Perspective: Return On Capital Employed - InnovAge Holding (NASDAQ:INNV) - BenzingaSeptember 15, 2022 | uk.investing.comWhy Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday By Benzinga - Investing.com UKSeptember 14, 2022 | fool.comInnovAge Holding Corp. (INNV) Q4 2022 Earnings Call Transcript - The Motley FoolSeptember 14, 2022 | finance.yahoo.comInnovAge Holding Corp. (INNV) Q4 2022 Earnings Call TranscriptSeptember 14, 2022 | finance.yahoo.comEdited Transcript of INNV.OQ earnings conference call or presentation 13-Sep-22 9:00pm GMT - Yahoo FinanceSeptember 14, 2022 | nasdaq.comInnovAge Holding Corp. (INNV) Reports Q4 Loss, Lags Revenue Estimates - NasdaqSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address INNV Company Calendar Last Earnings2/07/2023Today3/21/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Health services Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:INNV Previous SymbolNASDAQ:INNV CUSIPN/A CIK1411879 Webwww.innovuspharma.com Phone844-803-8745FaxN/AEmployees2,000Year FoundedN/APrice Target and Rating Average Stock Price Forecast$6.48 High Stock Price Forecast$9.00 Low Stock Price Forecast$3.90 Forecasted Upside/Downside+3.4%Consensus RatingHold Rating Score (0-4)1.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,520,000.00 Net Margins-5.57% Pretax Margin-7.37% Return on Equity-11.52% Return on Assets-6.84% Debt Debt-to-Equity Ratio0.24 Current Ratio1.88 Quick Ratio1.88 Sales & Book Value Annual Sales$698.64 million Price / Sales1.22 Cash Flow$0.09 per share Price / Cash Flow67.56 Book Value$2.50 per share Price / Book2.51Miscellaneous Outstanding Shares135,600,000Free Float135,257,000Market Cap$850.21 million OptionableNot Optionable Beta-0.01 Key ExecutivesMr. Patrick Blair (Age 52)Pres & CEO Comp: $1.48MMs. Barbara K. Gutierrez CPA (Age 60)Chief Financial Officer Comp: $625.45kMs. Nicole D'Amato (Age 44)Chief Legal Officer & Corp. Sec. Comp: $683.95kMr. Edward Moore Kennedy Jr. (Age 62)J.D., Independent Director Comp: $100kHon. Marilyn Barbour Tavenner M.H.A. (Age 72)R.N., Independent Director Comp: $120kMs. Maria Lozzano (Age 43)Chief Operating Officer Mr. Ryan KubotaDirector of Investor RelationsMs. Olivia PattonChief Compliance OfficerMs. Robin Doerr (Age 59)Chief Sales & Marketing Officer Mr. Rob BorellaChief Sales & Marketing OfficerMore ExecutivesKey CompetitorsSharecareNASDAQ:SHCRThe Pennant GroupNASDAQ:PNTGU.S. Physical TherapyNYSE:USPHCRH MedicalNYSEAMERICAN:CRHMLifeStance Health GroupNASDAQ:LFSTView All CompetitorsInsiders & InstitutionsAlliancebernstein L.P.Bought 4,000 shares on 2/16/2023Ownership: 0.022%T. Rowe Price Investment Management Inc.Bought 224,136 shares on 2/15/2023Ownership: 3.870%Morgan StanleyBought 7,179 shares on 2/15/2023Ownership: 0.011%Algert Global LLCBought 12,590 shares on 2/15/2023Ownership: 0.009%MetLife Investment Management LLCBought 11,572 shares on 2/15/2023Ownership: 0.009%View All Insider TransactionsView All Institutional Transactions INNV Stock - Frequently Asked Questions Should I buy or sell InnovAge stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last year. There are currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares. View INNV analyst ratings or view top-rated stocks. What is InnovAge's stock price forecast for 2023? 5 analysts have issued twelve-month target prices for InnovAge's shares. Their INNV share price forecasts range from $3.90 to $9.00. On average, they predict the company's stock price to reach $6.48 in the next twelve months. This suggests a possible upside of 3.4% from the stock's current price. View analysts price targets for INNV or view top-rated stocks among Wall Street analysts. How have INNV shares performed in 2023? InnovAge's stock was trading at $7.18 at the beginning of 2023. Since then, INNV shares have decreased by 12.7% and is now trading at $6.27. View the best growth stocks for 2023 here. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (OTCMKTS:INNV) released its quarterly earnings data on Tuesday, February, 7th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.04. The business earned $167.46 million during the quarter, compared to analysts' expectations of $170.22 million. InnovAge had a negative net margin of 5.57% and a negative trailing twelve-month return on equity of 11.52%. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some companies that other InnovAge investors own include EEStor Co. (ESU.V) (ESU), Antares Pharma (ATRS), Federal National Mortgage Association (FNMA), Medicines (MDCO), Frontier Communications (FTR), FedEx (FDX), Republic First Bancorp (FRBK), Aytu BioPharma (AYTU), NVIDIA (NVDA) and Pacific Premier Bancorp (PPBI). What is InnovAge's stock symbol? InnovAge trades on the OTCMKTS under the ticker symbol "INNV." Who are InnovAge's major shareholders? InnovAge's stock is owned by many different institutional and retail investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (3.87%), Geode Capital Management LLC (0.30%), Cambiar Investors LLC (0.23%), Renaissance Technologies LLC (0.09%), Strs Ohio (0.05%) and Martingale Asset Management L P (0.04%). Insiders that own company stock include Edward Moore Jr Kennedy, Maureen Hewitt and Thomas Scully. View institutional ownership trends. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is InnovAge's stock price today? One share of INNV stock can currently be purchased for approximately $6.27. How much money does InnovAge make? InnovAge (OTCMKTS:INNV) has a market capitalization of $850.21 million and generates $698.64 million in revenue each year. The company earns $-6,520,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis. How many employees does InnovAge have? The company employs 2,000 workers across the globe. How can I contact InnovAge? InnovAge's mailing address is 8845 Rehco Road, San Diego CA, 92121. The official website for the company is www.innovuspharma.com. The company can be reached via phone at 844-803-8745 or via email at ir@innovuspharma.com. This page (OTCMKTS:INNV) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.